Emcure Pharmaceuticals balance sheet

As of Mar 2026

Total assets: ₹9,612cr+16.8% on Mar 2025
Shareholders' equity: ₹4,977cr+7.2% on Mar 2025
Total debt: ₹1,204cr+64.6% on Mar 2025
Cash and investments: ₹137cr−41.0% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025

Non-current assets
	1,960	1,954
	172	124
	414	368
	945	875
	101	53.3
	19.7	19.3
	41.2	39.5
	60.9	58.8
	139	111
	111	38.9
	3,903	3,583
Current assets
	2,398	1,932
	0.0	76.0
	2,563	2,002
	137	156
	10.9	9.8
	68.7	52.5
	2,779	2,296
	435	328
	5,709	4,650
	9,612	8,233
Equity
	190	189
	4,760	4,257
	4,950	4,446
	26.6	195
	4,977	4,642
Liabilities
	252	190
	323	551
	576	741
	42.6	47.6
	98.0	120
	7.3	14.5
	724	923
	952	542
	1,808	1,480
	841	360
	3,600	2,381
	72.3	54.5
	143	112
	96.5	121
	3,912	2,668
	4,636	3,591
	9,612	8,233
Assets — additional as-filed lines
	96.9	94.0
Trade payables — MSME split
	91.6	32.3
	1,716	1,447

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

EMCURE₹1,775.90

Emcure Pharmaceuticals Ltd.

· Pharma & Health

₹ CrorePeersMANKIND ALKEM TORNTPHARM ERIS GRANULES CONCORDBIO INDGN CAPLIPOINTMcap ₹33,669 Cr

View

In ₹ Crore except Per Share As of	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,953.6	1,959.9	1,959.9
+ Capital Work-in-Progress	124.1	172.1	172.1
+ Goodwill	367.8	414.3	414.3
+ Other Intangibles	875.4	945.0	945.0
+ Intangibles under Development	53.3	100.6	100.6
+ Non-current Investments	19.3	19.7	19.7
+ Other Non-current Financial Assets	39.5	41.2	41.2
Non-current Financial Assets	58.8	60.9	60.9
+ Deferred Tax Assets	111.0	139.4	139.4
+ Other Non-current Assets	38.9	111.2	111.2
Total Non-current Assets	3,582.8	3,903.5	3,903.5
Current Assets
+ Inventories	1,931.8	2,397.9	2,397.9
+ Current Investments	76.0	0.0	0.0
+ Trade Receivables	2,002.2	2,562.7	2,562.7
+ Cash & Cash Equivalents	155.5	136.7	136.7
+ Other Bank Balances	9.8	10.9	10.9
+ Other Current Financial Assets	52.5	68.7	68.7
Current Financial Assets	2,296.1	2,778.9	2,778.9
+ Other Current Assets	327.9	435.3	435.3
Total Current Assets	4,649.9	5,709.0	5,709.0
Total Assets	8,232.7	9,612.5	9,612.5
Equity
+ Equity Share Capital	189.5	189.6	189.6
+ Other Equity / Reserves	4,256.7	4,760.4	4,760.4
Equity — Owners of Parent	4,446.2	4,950.0	4,950.0
+ Minority Interest	195.4	26.6	26.6
Total Equity	4,641.6	4,976.7	4,976.7
Liabilities
+ Borrowings — Non-current	189.9	252.2	252.2
+ Other Non-current Financial Liab	550.9	323.5	323.5
Non-current Financial Liabilities	740.8	575.7	575.7
+ Provisions — Non-current	47.6	42.6	42.6
+ Deferred Tax Liabilities	120.0	98.0	98.0
+ Other Non-current Liabilities	14.5	7.3	7.3
Non-current Liabilities	922.9	723.6	723.6
+ Borrowings — Current	541.8	951.9	951.9
+ Trade Payables	1,479.6	1,807.8	1,807.8
+ Other Current Financial Liab	359.5	840.8	840.8
Current Financial Liabilities	2,380.9	3,600.5	3,600.5
+ Provisions — Current	54.5	72.3	72.3
+ Current Tax Liabilities	112.3	143.0	143.0
+ Other Current Liabilities	120.6	96.5	96.5
Current Liabilities	2,668.3	3,912.2	3,912.2
Total Liabilities	3,591.2	4,635.8	4,635.8
Total Equity & Liabilities	8,232.7	9,612.5	9,612.5
Assets — additional as-filed lines
+ Current Tax Assets	94.0	96.9	96.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current	32.3	91.6	91.6
+ Dues to Other Creditors — Current	1,447.3	1,716.1	1,716.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.